Search filters

List of works by Karin Berger

A retrospective observational single-centre study on the burden of immune thrombocytopenia (ITP).

scientific article

Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care.

scientific article

Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study

scientific article published on 19 October 2006

Blood Product Supply in Germany: The Impact of Apheresis and Pooled Platelet Concentrates.

scientific article published on 15 September 2016

Burden of Oral Mucositis: A Systematic Review and Implications for Future Research

scientific article published on 03 May 2018

Burden of oral mucositis in stem cell transplant patients-the patients' perspective.

scientific article published on 2 December 2017

Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective

scientific article published on 15 September 2016

Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial

scientific article published on 01 August 2000

Cost of bacterial vaginosis in pregnancy. Decision analysis and cost evaluation of a clinical study in Germany

scientific article published on 01 September 1999

Cost of illness and its predictors for Parkinson's disease in Germany

scientific article published on 01 January 2005

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study.

scientific article published in January 2003

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

scientific article published on 01 November 1998

Costs of illness and care in Parkinson's disease: an evaluation in six countries

scientific article published on 01 February 2011

Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients.

scientific article

Economic and clinical aspects of intravenous versus oral busulfan in adult patients for conditioning prior to HSCT.

scientific article

Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis.

scientific article published on 6 September 2008

Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria.

scientific article published in February 2001

Economics of prophylactic treatment.

scientific article

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

scientific article published in June 2002

Haemophilia prophylaxis: how can we justify the costs? ⬇️

scientific article published on April 17, 2012

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany

scientific article published on 28 November 2006

Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients.

scientific article

Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias

scientific article

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population.

scientific article

Influencing blood usage in Germany: what is optimal use?

scientific article published on 01 August 2007

Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates

scientific article published on May 2014

Linking medicine and economics: health economics and quality of life in haemophilia care.

scientific article

Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.

scientific article published on 26 April 2011

Model calculations to quantify clinical and economic effects of pathogen inactivation in platelet concentrates.

scientific article published on 22 January 2013

Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany

scientific article published on 31 July 2008

Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective

scientific article published on 20 December 2016

Patient-reported measures of well-being in older multiple myeloma patients: use of secondary data source

scientific article published on 22 January 2020

Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary data.

scientific article published on 28 February 2018

Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.

scientific article published on 13 November 2007

Research in haemophilia B--approaching the request for high evidence levels in a rare disease

scientific article published on 11 December 2014

Socioeconomic evaluation in medicine in Europe. Core economic concepts.

scientific article

The Wildbad Kreuth initiative: European current practices and recommendations for optimal use of blood components

scientific article published on 23 April 2011

The economic burden of hepatitis B in Germany

scientific article published on 01 February 2000

The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

scientific article

The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care--an observational analysis on non-small-cell lung cancer patients.

scientific article published on 23 January 2013

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

scientific article published on 01 March 2004

Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for Germany.

scientific article published on 21 March 2013

Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany.

scientific article published on 20 August 2009

Wishes and worries of haemophilia patients. A patient survey from Bavaria.

scientific article published on 10 April 2017

[Combined hepatitis A/B immunization in children and adolescents. Economic evaluation of different immunization methods]

scientific article published on 01 June 1999

[Cost effectiveness of captopril after myocardial infarct; comment]

scientific article published on 01 February 1996

[Cost structure of hepatitis B infection]

scientific article published in February 1997

[Cost-utility analysis of contrast-enhanced MR angiography with automated table-translation for diagnosis and therapy planning in patients with peripheral vascular disease].

scientific article

[Economic evaluation of various hepatitis B vaccination strategies in children and adolescents]

scientific article published on 01 August 1998

[Health economic aspects of the use of blood and blood products]

scientific article published on 01 January 2006

[Pharmacoeconomic evaluation of pravastatin in the secondary prevention of coronary heart disease in patients with average cholesterol levels. An analysis for Germany based on the CARE study]

scientific article published on 01 August 1998

[Prophylactic factor substitution in severe haemophilia A. Economic assessment in adult patients]

scientific article published on 01 January 2014

[The use of coagulation factors in hemophilia treatment]

scientific article published on 01 January 2006

Paulina is supported by:

About Paulina

Help